Biosimilars 2018 Report

We delightedly thank all our wonderful Keynote Speakers, Speakers, Conference Attendees, Students, Organizing Committee Members, Associations, Sponsors and Media Partners for making Biosimilars 2018 Conference a Successful event!

The “13^th International Conference on Biologics and Biosimilars”, hosted by the Conference series LLC Ltd was held during October 24-25, 2018 at Boston, USA based on the theme “
Emerging Trends in Biosimilars Development and Approval”. Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of biopharmaceuticals, biotherapeutics, medical groups, related associations, societies and related government agencies.

Conference series LLC Ltd expresses its gratitude to the conference Moderators, namely Ha Kung Wong and Karlheinz Landauer for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Chairs of the sessions for 2 days, namely Peter H Kalinka and Louis Boon.

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

• Francois-Xavier Frapaise, Biosimilars Consultant Paris, France
• Peter H Kalinka, Longmore 60 Biotech Inc., USA
• Thomas J Webster, Northeastern University, USA
• Leigh Ann M Durant, EMD, Serono, Inc., USA
• Aruna Dontabhaktuni, PharmaPro Consulting Inc, USA
• Ha Kung Wong, Fitzpatrick Cella Harper & Scinto, US
• Stanton R Mehr, Biosimilars Review & Reports, USA
• Himabindu Gaddipati, Elixsys, Inc., USA

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

• Current Challenges in Developing Biosimilars
• Emerging Biosimilars in Therapeutics
•  Biosimilars Analytical Strategies
•  Regulatory Approach for Biosimilars
• Legal Issues and BPCI Act
•  Biosimilars Research Pipeline
• Globalization of Biosimilars
• Clinical Development Of Biosimilars
• Intellectual Property Rights
•  Bioequivalence Assessment
• BCS and IVIVC Based Biowaivers
•  Biosimilar Companies and Market Analysis
• Challenges in Biosimilars Pharmacovigilance
• Brexit Effect on Biosimilars
• Entrepreneurs Investment Meet
• Biopharmaceuticals
• Drug Delivery and Development
• Current Trends in Pharmaceutical industry

 Conference Series offers its heartfelt appreciation to organizations such as EventsGet, Clocate, Kind Congress, Tabeeby, Technology Networks, Oncology Directory, Course for Doctors, Copybook, Event listing sites of Boston, and other eminent personalities namely Francois Xavier Frapaise, Peter Kalinka,  Stanton Mehr, Ha Kung Wong and Karlheinz Landauer who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. 

With the grand success of Biosimilars 2018, Conference Series LLC Ltd is proud to announce the “14^th International Conference on Biologics and Biosimilars” August 2-3, 2019 at Chicago, USA

For More details visit:https://biosimilars-biologics.pharmaceuticalconferences.com/

Let us meet again

@ 

Biosimilars 2019